Adverse events (participants) · people with critical limb ischaemia
It is very uncertain whether prostanoids changes adverse events (participants) compared with pentoxifylline (very low certainty).
1 finding from 1 review
Adverse events (participants) · people with critical limb ischaemia
Prostanoids showed no clear difference in adverse events (participants) compared with naftidrofuryl (low certainty).
1 finding from 1 review
Adverse events (participants) · people with critical limb ischaemia
PGE1 showed no clear difference in adverse events (participants) compared with inositol niacinate (low certainty).
1 finding from 1 review
Adverse events (participants) · people with critical limb ischaemia
Iloprost probably leads to higher adverse events (participants) compared with PGE1 (moderate certainty).
1 finding from 1 review
Adverse events (participants) · people with critical limb ischaemia
Prostanoids probably leads to higher adverse events (participants) compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular adverse events
Naftopidil showed no clear difference in cardiovascular adverse events compared with tamsulosin (alpha‐blocker) (low certainty).
1 finding from 1 review
Cardiovascular adverse events
Naftopidil showed no clear difference in cardiovascular adverse events compared with silodosin (alpha‐blocker) (low certainty).
1 finding from 1 review
Adverse events ‐ not reported · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · symptomatic gastroparesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events WMD of · Adults (aged 40 or over) with COPD presenting with 1 or more exacerbations in the previous year. The 2 larger studies (Albert 2011; Sethi…
Antibiotics showed no clear difference in serious adverse events WMD of compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events: death · Dialysis vascular access outcomes in AVF patients with ESKD
Omega‐3 fatty acids showed no clear difference in serious adverse events: death compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events: death · dialysis vascular access outcomes in AVG patients with ESKD
Omega‐3 fatty acids showed no clear difference in serious adverse events: death compared with placebo (low certainty).
1 finding from 1 review
Constipation · acute infectious diarrhoea in children
Smectite showed no clear difference in adverse events – constipation compared with control (low certainty).
1 finding from 1 review
Adverse events ‐ not reported · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found